NCT05248035

Brief Summary

Delirium in intensive care unit (ICU) is a serious event. It is associated with short-term complications (agitation, self-extubation, accidental removal of catheters, prolonged length of stay and ventilation), excess mortality, functional and cognitive impairment. It is particularly frequent in patients requiring mechanical ventilation but diagnosis is not easy. There are screening scales, but it is insufficiently used in clinical practice: Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) or Intensive Care Delirium Screening Checklist (ICDSC). These scales are time consuming and require trained personnel. Automated pupillometry (AP) is a new device to objectively, rapidly, and reproducibly identify acute brain dysfunction. Recent data suggest that AP could be used to predict delirium in the ICU. This would need to be validated for routine use in the ICU. Evaluate AP parameters on day 3 of invasive mechanical ventilation as a predictive tool for CAM-ICU diagnosed delirium during the first 14 days of ICU stay. Study design: Prospective, multicenter, non-interventional cohort Measurement of the AP parameters at day 3 after ICU admission and their predictive performance for delirium: pupillary diameter, variation of the pupillary diameter, pupillary constriction speed, pupillary dilatation speed, photomotor reflex latency, NPi and symmetry of pupillary responses.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
213

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 9, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 21, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

April 15, 2022

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2024

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

January 12, 2026

Status Verified

January 1, 2026

Enrollment Period

2.6 years

First QC Date

December 9, 2021

Last Update Submit

January 8, 2026

Conditions

Keywords

Automated Pupillometry Delirium ICU

Outcome Measures

Primary Outcomes (1)

  • Measurement of the parameters of the automated pupillometry

    at day 0

Secondary Outcomes (10)

  • Measurement of the parameters of the automated pupillometry

    until 7 days

  • Rate of agitated patients (agitation is defined by a Richmond Agitation-Sedation Scale > +1(RASS score: +4; -5 with 0= better outcome) requiring use of neuroleptics or dexmedetomidine)

    until day14 of resuscitation or discharge from resuscitation

  • Self-extubation rate

    until day14 or stop invasive ventilation

  • Accidental catheter ablation rate

    up to day14 resuscitation or resuscitation discharge

  • Number of days of mechanical ventilation

    until D14 or stopping invasive ventilation

  • +5 more secondary outcomes

Study Arms (1)

Patient

Adult patient hospitalized in ICU for a duration of mechanical ventilation longer than 48 hours

Other: Adult patient hospitalized in ICU

Interventions

acquisition of dynamic parameters in addition to pupillary diameter, such as . pupillary diameter, variation of the pupillary diameter, pupillary constriction speed, pupillary dilatation speed, photomotor reflex latency, NPi and symmetry of pupillary responses after a standardized light stimulus

Patient

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patient hospitalized in ICU for a duration of mechanical ventilation longer than 48 hours

You may qualify if:

  • Adults ≥ 18 years
  • mechanical ventilation since 48h

You may not qualify if:

  • Patient diagnosed confused by CAM-ICU on D0
  • Ophthalmological pathology modifying the photomotor reflex
  • Acute or chronic neurological pathology: Cerebro-injured patients (head trauma, stroke, cardiopulmonary arrest, hypoglycemic coma, meningitis / encephalitis / brain abscess), dementia with MMSE \<24
  • Duration of stay in intensive care\> 72h or duration of ventilation\> 72h
  • Readmission in intensive care
  • Moribund patient
  • Patient under guardianship or curatorship
  • No affiliation to social security (beneficiary or assignee)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Bichat-Claude Bernard

Paris, 75018, France

Location

Related Publications (1)

  • Jaquet P, Couffignal C, Tardivon C, Godard V, Bellot R, Assouline B, Benghanem S, Da Silva D, Decavele M, Dessajan J, Hermann B, Rambaud T, Voiriot G, Sonneville R; PODIUM Study Group. PupillOmetry for preDIction of DeliriUM in ICU (PODIUM): protocol for a prospective multicentre cohort study. BMJ Open. 2023 Jul 12;13(7):e072095. doi: 10.1136/bmjopen-2023-072095.

MeSH Terms

Conditions

Delirium

Interventions

Intensive Care Units

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Hospital UnitsHealth FacilitiesHealth Care Facilities Workforce and Services

Study Officials

  • Pierre Jaquet, MD

    Assistance Publique Hopitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2021

First Posted

February 21, 2022

Study Start

April 15, 2022

Primary Completion

November 15, 2024

Study Completion

March 1, 2026

Last Updated

January 12, 2026

Record last verified: 2026-01

Locations